We are live on ! Find out more
ACH

Accendra Health

273 hedge funds and large institutions have $1.95B invested in Accendra Health in 2017 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 132 increasing their positions, 83 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more repeat investments, than reductions

Existing positions increased: 132 | Existing positions reduced: 83

4% more call options, than puts

Call options by funds: $341K | Put options by funds: $327K

0.94% less ownership

Funds ownership: 100.01%99.08% (-0.94%)

4% less funds holding

Funds holding: 284273 (-11)

8% less capital invested

Capital invested by funds: $2.11B → $1.95B (-$163M)

25% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 36

Holders
273
Holders Change
-11
Holders Change %
-3.87%
% of All Funds
6.8%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
27
Increased
132
Reduced
83
Closed
36
Calls
$341K
Puts
$327K
Net Calls
+$14K
Net Calls Change
+$168K

ACH Hedge Fund Activity: Q2 2017 in Review

273 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q2 2017, worth a combined $1.95B — down 7.7% from $2.11B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of ACH and 27 opened new positions — a net loss of 9 holders — while 83 trimmed existing stakes and 132 added.

The largest buyer was Balyasny Asset Management, adding an estimated $31.1M. The largest seller was Acadian Asset Management, cutting an estimated $36.2M.

  • 273 institutional investors held Accendra Health (ACH) as of Q2 2017, down from 284 in Q1 2017.
  • Funds reported $1.95B of Accendra Health stock for Q2 2017, down 7.7% quarter-over-quarter.
  • 27 funds opened new Accendra Health positions in Q2 2017 and 36 closed out, a net change of -9 holders.
  • The largest Accendra Health buyer in Q2 2017 was Balyasny Asset Management, an estimated $31.1M added.
  • The largest Accendra Health seller in Q2 2017 was Acadian Asset Management, an estimated $36.2M sold.

Based on aggregated 13F filings for Q2 2017.